📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults. (2018)

First Author: Coughlan L

Attributed to: Clinical assessment of a novel simian adenovirus-vectored influenza vaccine designed to induce broadly protective immunity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2018.02.011

PubMed Identifier: 29519670

Publication URI: http://europepmc.org/abstract/MED/29519670

Type: Journal Article/Review

Volume: 29

Parent Publication: EBioMedicine

ISSN: 2352-3964